TY  - JOUR
VL  - 99
EP  - 131
ID  - eprints667
N2  - This paper shows that the relationships between the dynamics of drug priees, patent expiry, and competition by multisource
drugs vary significantly across countries. A clear distinction seems to emerge. On the one side, systems that rely on market
based competition (particularly the US) promote a clear distinction between firms that act as innovators and firms that act as
imitators after patent expiry. Original products enjoy premium prices under patent protection, and face fierce price competition
after patent expiry. On the contrary, systems that rely on administered prices (particularly France and Italy) nurture strategies of
pre-emptive brand proliferation and horizontal differentiation by imitative brand name products, well before patent expiry. Our
work confirms that that systems that rely on administered prices have tended to stifle price competition, to protect less efficient
companies, and to encourage strategies of incremental innovation and imitation.
SP  - 107
A1  - Pammolli, Fabio
A1  - Magazzini, Laura
A1  - Orsenigo, Luigi
SN  - 0154-3229
UR  - http://www.persee.fr/web/revues/home/prescript/article/rei?????????????num???????
JF  - Revue d'economie industrielle
IS  - 1
TI  - The intensity of competition after patent expiry in pharmaceuticals. A cross-country analysis
AV  - public
Y1  - 2002///
ER  -